Pfizer loses U.S. appeal over co-pays for heart failure patients
By Jonathan Stempel NEW YORK (Reuters) - A federal appeals court on Monday rejected Pfizer Inc's challenge to a U.S. anti-kickback law that the drugma...
Stay updated with breaking news from Direct Copay Assistance Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Jonathan Stempel NEW YORK (Reuters) - A federal appeals court on Monday rejected Pfizer Inc's challenge to a U.S. anti-kickback law that the drugma...
By Jonathan Stempel NEW YORK (Reuters) - A federal appeals court on Monday rejected Pfizer Inc's challenge to a U.S. anti-kickback law that the drugma...
Key Points - Patient outcomes studies suggest a clinical benefit of co-pay programs, and a negative impact of co-pay accumulator programs. Co-pay programs...
Patient outcomes studies suggest a clinical benefit of co-pay programs, and a negative impact of co-pay accumulator programs.
Pfizer brought suit in direct challenge to application of health care fraud prohibitions enforced by Office of Inspector General for U.S. Department of Health and Human Services in S.D.N.Y, financial assistance to qualifying Medicare beneficiaries for tafamidis no AKS/BIS violation